Whether in search of relatives, a family's country of origin, or to understand personal disease risk, 15 million people have shared their DNA with 23andMe since the genetic test site launched in 2006. However, many who gave their saliva in exchange for genetic information and family history now wonder where that data will go, and how it will be used given that the future of the company is unclear.
Last year, 23andMe came under fire following a massive data breach affecting 7 million customers that led to a class action lawsuit and a $30 million settlement. To make matters worse, last month, all seven independent board members of the biotech company, whose shares have plummeted, resigned, citing hesitancy over CEO Anne Wojcicki’s strategy for the company.
